{"id":"https://openalex.org/W1837457249","doi":"https://doi.org/10.1186/1471-2407-5-151","title":"First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study","display_name":"First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study","publication_year":2005,"publication_date":"2005-11-29","ids":{"openalex":"https://openalex.org/W1837457249","doi":"https://doi.org/10.1186/1471-2407-5-151","mag":"1837457249","pmid":"https://pubmed.ncbi.nlm.nih.gov/16316459","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1315334"},"language":"en","primary_location":{"id":"doi:10.1186/1471-2407-5-151","doi":"https://doi.org/10.1186/1471-2407-5-151","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1471-2407-5-151","pdf_url":"https://bmccancer.biomedcentral.com/counter/pdf/10.1186/1471-2407-5-151","source":{"id":"https://openalex.org/S192926780","display_name":"BMC Cancer","issn_l":"1471-2407","issn":["1471-2407"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://bmccancer.biomedcentral.com/counter/pdf/10.1186/1471-2407-5-151","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046156275","display_name":"Djelila Allouache","orcid":"https://orcid.org/0009-0009-3693-3199","observed_orcids":["https://orcid.org/0009-0009-3693-3199"]},"institutions":[{"id":"https://openalex.org/I4210121964","display_name":"Centre Fran\u00e7ois Baclesse","ror":"https://ror.org/02x9y0j10","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210121964"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Djelila Allouache","raw_affiliation_strings":["Centre F. Baclesse, Lion Sur Mer, 14076 Caen Cedex 05, France. d.allouache@baclesse.fr","Centre F. Baclesse, Lion sur mer, CAEN Cedex 05, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre F. Baclesse, Lion Sur Mer, 14076 Caen Cedex 05, France. d.allouache@baclesse.fr","institution_ids":["https://openalex.org/I4210121964"]},{"raw_affiliation_string":"Centre F. Baclesse, Lion sur mer, CAEN Cedex 05, France","institution_ids":["https://openalex.org/I4210121964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065561614","display_name":"Sulochana R. Gawande","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sulochana R Gawande","raw_affiliation_strings":["Eli Lilly and Company, Lilly Corporate, Indianapolis, IN, 46285, USA","Eli Lilly and Company, Lilly Corporate, Indianapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Lilly Corporate, Indianapolis, IN, 46285, USA","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Eli Lilly and Company, Lilly Corporate, Indianapolis, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012336750","display_name":"Michele Tubiana-Hulin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116453","display_name":"H\u00f4pital Ren\u00e9 Huguenin","ror":"https://ror.org/0263jp665","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210116453"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Michele Tubiana-Hulin","raw_affiliation_strings":["Ctr Ren\u00e9 Huguenin, 35 rue Dailly, 92210, Saint-Cloud, France","Ctr Ren\u00e9 Huguenin, Saint-Cloud, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ctr Ren\u00e9 Huguenin, 35 rue Dailly, 92210, Saint-Cloud, France","institution_ids":["https://openalex.org/I4210116453"]},{"raw_affiliation_string":"Ctr Ren\u00e9 Huguenin, Saint-Cloud, France","institution_ids":["https://openalex.org/I4210116453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085315048","display_name":"N. Tubiana-Mathieu","orcid":"https://orcid.org/0000-0001-7849-3667","observed_orcids":["https://orcid.org/0000-0001-7849-3667"]},"institutions":[{"id":"https://openalex.org/I4210142031","display_name":"H\u00f4pital Universitaire Dupuytren","ror":"https://ror.org/051s3e988","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210142031"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nicole Tubiana-Mathieu","raw_affiliation_strings":["Hopital Dupuytren, 2 avenue Martin Luther King, 87042, Limoges, France","Hopital Dupuytren, Limoges, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hopital Dupuytren, 2 avenue Martin Luther King, 87042, Limoges, France","institution_ids":["https://openalex.org/I4210142031"]},{"raw_affiliation_string":"Hopital Dupuytren, Limoges, France","institution_ids":["https://openalex.org/I4210142031"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066286234","display_name":"Sophie Piperno-Neumann","orcid":"https://orcid.org/0000-0001-9915-2810","observed_orcids":["https://orcid.org/0000-0001-9915-2810"]},"institutions":[{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Sophie Piperno-Neumann","raw_affiliation_strings":["Hospital Curie, 26 rue Ulm, 75005, Paris, France","Hospital Curie, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Curie, 26 rue Ulm, 75005, Paris, France","institution_ids":[]},{"raw_affiliation_string":"Hospital Curie, Paris, France","institution_ids":["https://openalex.org/I80043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061807618","display_name":"Fawzia Mefti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116453","display_name":"H\u00f4pital Ren\u00e9 Huguenin","ror":"https://ror.org/0263jp665","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210116453"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fawzia Mefti","raw_affiliation_strings":["Ctr Ren\u00e9 Huguenin, 35 rue Dailly, 92210, Saint-Cloud, France","Ctr Ren\u00e9 Huguenin, Saint-Cloud, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ctr Ren\u00e9 Huguenin, 35 rue Dailly, 92210, Saint-Cloud, France","institution_ids":["https://openalex.org/I4210116453"]},{"raw_affiliation_string":"Ctr Ren\u00e9 Huguenin, Saint-Cloud, France","institution_ids":["https://openalex.org/I4210116453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023813062","display_name":"Laurence Bozec","orcid":"https://orcid.org/0000-0001-6443-9360","observed_orcids":["https://orcid.org/0000-0001-6443-9360"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laurence Bozec","raw_affiliation_strings":["Lilly France, 13 rue Pag\u00e8s, 92158, Suresnes Cedex, France","Lilly France, Suresnes Cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly France, 13 rue Pag\u00e8s, 92158, Suresnes Cedex, France","institution_ids":[]},{"raw_affiliation_string":"Lilly France, Suresnes Cedex, France","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111677174","display_name":"Jean-Yves G\u00e9not","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121964","display_name":"Centre Fran\u00e7ois Baclesse","ror":"https://ror.org/02x9y0j10","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210121964"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Jean-Yves Genot","raw_affiliation_strings":["Centre F. Baclesse, Lion sur mer, 14076, CAEN Cedex 05, France","Centre F. Baclesse, Lion sur mer, CAEN Cedex 05, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre F. Baclesse, Lion sur mer, 14076, CAEN Cedex 05, France","institution_ids":["https://openalex.org/I4210121964"]},{"raw_affiliation_string":"Centre F. Baclesse, Lion sur mer, CAEN Cedex 05, France","institution_ids":["https://openalex.org/I4210121964"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5111677174"],"corresponding_institution_ids":["https://openalex.org/I4210121964"],"apc_list":{"value":3390,"currency":"USD","value_usd":3390},"apc_paid":{"value":3390,"currency":"USD","value_usd":3390},"fwci":1.5507,"has_fulltext":true,"cited_by_count":28,"citation_normalized_percentile":{"value":0.82004283,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"5","issue":"1","first_page":"151","last_page":"151"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.9307000041007996,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.9307000041007996,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.06679999828338623,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9810000061988831},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":1.0},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9449999928474426},{"id":"https://openalex.org/keywords/locally-advanced-breast-cancer","display_name":"locally advanced breast cancer","score":0.9340000152587891},{"id":"https://openalex.org/keywords/breast-cancer-recurrence","display_name":"breast cancer recurrence","score":0.9679999947547913},{"id":"https://openalex.org/keywords/first-line-chemotherapy","display_name":"first-line chemotherapy","score":0.972000002861023},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.8050000071525574},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.6949999928474426},{"id":"https://openalex.org/keywords/alopecia","display_name":"hair loss","score":0.621999979019165},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.6200000047683716},{"id":"https://openalex.org/keywords/overall-response-rate","display_name":"overall response rate","score":0.628000020980835},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.621999979019165}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9381322860717773},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.7899933457374573},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.7396213412284851},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7337932586669922},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6453261971473694},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.635869026184082},{"id":"https://openalex.org/C2780140570","wikidata":"https://www.wikidata.org/wiki/Q3545481","display_name":"Surgical oncology","level":2,"score":0.5420942306518555},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5243740081787109},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5188432931900024},{"id":"https://openalex.org/C2780873365","wikidata":"https://www.wikidata.org/wiki/Q496812","display_name":"Leukopenia","level":3,"score":0.5143367052078247},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.46947750449180603},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.44863834977149963},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.44382524490356445},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.4191967248916626},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.40455639362335205},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3923877775669098},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3298998475074768},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000093542","descriptor_name":"Gemcitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1186/1471-2407-5-151","doi":"https://doi.org/10.1186/1471-2407-5-151","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1471-2407-5-151","pdf_url":"https://bmccancer.biomedcentral.com/counter/pdf/10.1186/1471-2407-5-151","source":{"id":"https://openalex.org/S192926780","display_name":"BMC Cancer","issn_l":"1471-2407","issn":["1471-2407"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:98385","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC1315334","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmid:16316459","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16316459","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC cancer","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:pubmedcentral.nih.gov:1315334","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1315334/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:728dda3476ca40d894407659bb8912b3","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/728dda3476ca40d894407659bb8912b3","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"BMC Cancer, Vol 5, Iss 1, p 151 (2005)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/1471-2407-5-151","doi":"https://doi.org/10.1186/1471-2407-5-151","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1471-2407-5-151","pdf_url":"https://bmccancer.biomedcentral.com/counter/pdf/10.1186/1471-2407-5-151","source":{"id":"https://openalex.org/S192926780","display_name":"BMC Cancer","issn_l":"1471-2407","issn":["1471-2407"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1837457249.pdf","grobid_xml":"https://content.openalex.org/works/W1837457249.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W18214132","https://openalex.org/W37295386","https://openalex.org/W1520702439","https://openalex.org/W1812067939","https://openalex.org/W1898871412","https://openalex.org/W1946759281","https://openalex.org/W1971473564","https://openalex.org/W1997838307","https://openalex.org/W1999879350","https://openalex.org/W1999982168","https://openalex.org/W2009930501","https://openalex.org/W2010341976","https://openalex.org/W2013246214","https://openalex.org/W2037605675","https://openalex.org/W2044573147","https://openalex.org/W2045316633","https://openalex.org/W2067120001","https://openalex.org/W2068532424","https://openalex.org/W2069588715","https://openalex.org/W2083470546","https://openalex.org/W2128848742","https://openalex.org/W2131770017","https://openalex.org/W2133243551","https://openalex.org/W2139861053","https://openalex.org/W2143989581","https://openalex.org/W2157800681","https://openalex.org/W2169073956","https://openalex.org/W2178225042","https://openalex.org/W2182111422","https://openalex.org/W2294342511","https://openalex.org/W2329401292","https://openalex.org/W4255152173"],"related_works":["https://openalex.org/W2133903708","https://openalex.org/W2069588715","https://openalex.org/W2993398695","https://openalex.org/W2051992029","https://openalex.org/W1753526066","https://openalex.org/W2415573191","https://openalex.org/W2020622202","https://openalex.org/W2133804515","https://openalex.org/W2246215909","https://openalex.org/W1997838307"],"abstract_inverted_index":{"BACKGROUND:":[0],"This":[1],"phase":[2],"II":[3],"study":[4],"evaluated":[5],"the":[6,143,171],"efficacy":[7,170],"and":[8,34,48,50,75,87,110,151,182,222,242],"safety":[9],"of":[10,65,97,126,133,160,190],"gemcitabine":[11],"(G)":[12],"plus":[13],"paclitaxel":[14],"(T)":[15],"as":[16,245],"first-line":[17,246],"therapy":[18,247],"in":[19,211,219,226,248],"recurrent":[20,29],"or":[21,30,99,112],"metastatic":[22,31,39,72,114,249],"breast":[23,32,73,250],"cancer.":[24,251],"METHODS:":[25],"Patients":[26],"with":[27],"locally,":[28],"cancer":[33,74],"no":[35],"prior":[36,122,129],"chemotherapy":[37],"for":[38,62,155,162,169,255],"disease":[40],"received":[41],"G":[42],"1200":[43],"mg/m2":[44,53],"on":[45,54],"days":[46,61],"1":[47,56,76,230],"8,":[49],"T":[51],"175":[52],"day":[55],"(before":[57],"G)":[58],"every":[59],"21":[60],"a":[63,90],"maximum":[64],"10":[66],"cycles.":[67],"RESULTS:":[68],"Forty":[69],"patients,":[70,146],"39":[71],"locally-advanced":[77],"disease,":[78,181],"were":[79,140,209],"enrolled.":[80],"Their":[81],"median":[82,188,195,201],"age":[83],"was":[84,174,192],"61.5":[85],"years,":[86],"85%":[88],"had":[89,121,128,148,179,184,233],"World":[91],"Health":[92],"Organization":[93],"performance":[94],"status":[95],"(PS)":[96],"0":[98],"1.":[100],"Poor":[101],"prognostic":[102],"factors":[103],"at":[104],"baseline":[105],"included":[106],"visceral":[107],"involvement":[108],"(87.5%)":[109],">":[111],"=2":[113],"sites":[115],"(70%).":[116],"Also,":[117],"27":[118],"(67.5%)":[119],"patients":[120,167,178,214],"adjuvant":[123],"chemotherapy,":[124],"25":[125],"which":[127],"anthracyclines.":[130],"A":[131],"total":[132],"220":[134],"cycles":[135],"(median":[136],"6;":[137],"range,":[138],"1-10)":[139],"administered.":[141],"Of":[142],"40":[144],"enrolled":[145],"2":[147],"complete":[149],"response":[150,158,172,191],"12":[152,193],"partial":[153],"response,":[154],"an":[156],"overall":[157],"rate":[159,173],"35.0%":[161],"intent-to-treat":[163],"population.":[164],"Among":[165],"35":[166],"evaluable":[168],"40%.":[175],"Additional":[176],"14":[177],"stable":[180],"7":[183],"progressive":[185],"disease.":[186],"The":[187],"duration":[189],"months;":[194,200],"time":[196],"to":[197],"progression,":[198],"7.2":[199],"survival,":[202],"25.7":[203],"months.":[204],"Common":[205],"grade":[206,216,223,234],"3/4":[207],"toxicities":[208],"neutropenia":[210],"17":[212],"(42.5%)":[213],"each,":[215],"3":[217,224],"leukopenia":[218],"19":[220],"(47.5%),":[221],"alopecia":[225],"30":[227],"(75.0%)":[228],"patients;":[229],"(2.5%)":[231],"patient":[232],"4":[235],"thrombocytopenia.":[236],"CONCLUSION:":[237],"GT":[238],"exhibited":[239],"encouraging":[240],"activity":[241],"tolerable":[243],"toxicity":[244],"Phase":[252],"III":[253],"trials":[254],"further":[256],"evaluation":[257],"are":[258],"ongoing.":[259]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}